The latest news from The VIVA Foundation
Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.
News & Updates
First-on-Podium Data from 21 Vascular and Venous Clinical Trials to Be Presented at The VEINS and VIVA 2024
September 6, 2024Leading physicians and researchers will present results from 21 clinical trials from Sunday, November 3, to Tuesday, November 5, at the annual VIVA and The VEINS conferences at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) is a vascular education symposium that emphasizes innovation and multidisciplinary lear ...
News & Updates
The VIVA Foundation Welcomes New Members, Dr. Brian DeRubertis and Dr. Kathleen Gibson to Board of Directors
July 28, 2024The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education, research, advocacy, and collaboration, has appointed Brian G. DeRubertis, MD, and Kathleen Gibson, MD, as the newest members of the Board of Directors. Drs. DeRubertis and Gibson ...
News & Updates
A new ground-breaking clinical trial exploring treatments for pelvic venous disorders has launched
March 25, 2024SIR Foundation, The VIVA Foundation, and Penumbra, Inc., announce the start of the EMBOLIZE Trial SALT LAKE CITY (March 25, 2024)—The Society of Interventional Radiology (SIR) Foundation, The VIVA Foundation and Penumbra, Inc., today announced the launch of the EMBOLIZE trial, a first-of-its-kind prospective, randomiz ...
News & Updates
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA23
November 1, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the last of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Adv ...
News & Updates
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA23
November 1, 2023The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four Late-Breaking Clinical Trial sessions at the VIVA23 conference, hosted at Wynn Las Vegas. VIVA (Vascular InterVentional Ad ...